The maximum number of dependent data points was 51 with a large number of variables to consider; however, the best models had less than ten variables each. We kept “outliers” in the analysis because we consider they speak to real extreme state cases and not to data deformities, and examined quantile–quantile (Q–Q) plots to determine whether additional transformations were needed. Models were evaluated on adjusted R-square values and the F-statistic, with an individual variable evaluated on its p-value (below 5%). The regressions were performed with R statistical software package version 2.11.1 [36]. Some descriptive

statistics were calculated in Microsoft Excel versions 11 and 12. Seven variables including lead-time from allocation

to ordering and shipment, the maximum number of ship-to sites per thousand population, past seasonal influenza coverage for non-high risk adults age 18–49, percentage selleck of doses categorized as sent to internists and specialists, percentage of women 18 and older with a Pap smear in the last three years, percentage of weeks with ILI above 2.3 after week 30, and the percentage of residents mTOR kinase assay of Hispanic or Latino origin were significant for predicting vaccination coverage in adults (Table 1). The best model found explained the variation in state-specific adult vaccination coverage with an adjusted R-squared of 0.76 and a p-value

close to 0 ( Table 2). For supply decisions, a long lead-time was associated with lower coverage, and the associated coefficient has a relatively large magnitude. Additional analysis of lead-time indicated that a state’s relative lag tended to be consistent throughout the months considered. We also found that lead-time is correlated with some variables related to shipment choice (e.g., positively with use of third parties for distribution, and negatively with shipments per ship-to site). The vaccine allocated to internists and specialists as a percentage of the total shipped was negatively associated with coverage, and having a large number of maximum ship-to sites was positively associated with coverage. Vaccination coverage was positively associated with past influenza vaccination coverage; while we found a strong mafosfamide association, there were several other effects that were also large in magnitude. Coverage was also positively associated with the percentage of women with a Pap smear, and the percent of the population that is Hispanic. A long duration of ILI severity peaks (defined by the percentage of weeks in the Fall with percent ILI more than 2.3) was negatively associated with coverage. To provide more information on our modeling, Supplementary Table 2 presents examples of other variables highly correlated with those factors in our final model.